Free Trial

Chemed (CHE) Stock Price, News & Analysis

Chemed logo
$561.15 -13.59 (-2.36%)
Closing price 03:59 PM Eastern
Extended Trading
$560.75 -0.40 (-0.07%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chemed Stock (NYSE:CHE)

Key Stats

Today's Range
$549.21
$577.30
50-Day Range
$517.44
$574.26
52-Week Range
$512.12
$654.62
Volume
170,510 shs
Average Volume
98,275 shs
Market Capitalization
$8.45 billion
P/E Ratio
28.36
Dividend Yield
0.36%
Price Target
$641.50
Consensus Rating
Buy

Company Overview

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Chemed Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
99th Percentile Overall Score

CHE MarketRank™: 

Chemed scored higher than 99% of companies evaluated by MarketBeat, and ranked 17th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Chemed has only been the subject of 1 research reports in the past 90 days.

  • Read more about Chemed's stock forecast and price target.
  • Earnings Growth

    Earnings for Chemed are expected to grow by 8.73% in the coming year, from $21.43 to $23.30 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemed is 28.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.07.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemed is 28.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 88.73.

  • Price to Earnings Growth Ratio

    Chemed has a PEG Ratio of 2.15. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Chemed has a P/B Ratio of 7.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemed's valuation and earnings.
  • Percentage of Shares Shorted

    1.88% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently increased by 3.88%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Chemed has a dividend yield of 0.36%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemed has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Chemed is 10.11%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chemed will have a dividend payout ratio of 8.58% next year. This indicates that Chemed will be able to sustain or increase its dividend.

  • Read more about Chemed's dividend.
  • Percentage of Shares Shorted

    1.88% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently increased by 3.88%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Chemed has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Chemed this week, compared to 6 articles on an average week.
  • Search Interest

    5 people have searched for CHE on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Chemed to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemed insiders have sold 1,980.10% more of their company's stock than they have bought. Specifically, they have bought $75,328.00 in company stock and sold $1,566,894.00 in company stock.

  • Percentage Held by Insiders

    Only 3.32% of the stock of Chemed is held by insiders.

  • Percentage Held by Institutions

    95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemed's insider trading history.
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

Must-See: 5-Second Trump Prediction
President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration.
See More Headlines

CHE Stock Analysis - Frequently Asked Questions

Chemed's stock was trading at $529.80 at the start of the year. Since then, CHE stock has increased by 6.0% and is now trading at $561.3270.
View the best growth stocks for 2025 here
.

Chemed Co. (NYSE:CHE) released its quarterly earnings results on Tuesday, October, 29th. The company reported $5.64 EPS for the quarter, missing analysts' consensus estimates of $5.76 by $0.12. The firm's revenue for the quarter was up 7.4% on a year-over-year basis.

Chemed's top institutional shareholders include Boston Trust Walden Corp (1.61%), Copeland Capital Management LLC (1.01%), Riverbridge Partners LLC (0.52%) and Retirement Systems of Alabama (0.28%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Nicholas Michael Westfall, Andrea R Lindell, Donald E Saunders, Patrick P Grace, George J Walsh III, Michael D Witzeman and Brian C Judkins.
View institutional ownership trends
.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
10/29/2024
Ex-Dividend for 12/6 Dividend
11/18/2024
Dividend Payable
12/06/2024
Today
1/28/2025
Next Earnings (Estimated)
2/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
Health Care Services
CUSIP
16359R10
Employees
15,087
Year Founded
1970

Price Target and Rating

Average Stock Price Target
$641.50
High Stock Price Target
$650.00
Low Stock Price Target
$633.00
Potential Upside/Downside
+14.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$272.51 million
Pretax Margin
16.61%

Debt

Sales & Book Value

Annual Sales
$2.26 billion
Cash Flow
$25.01 per share
Book Value
$73.55 per share

Miscellaneous

Free Float
14,550,000
Market Cap
$8.45 billion
Optionable
Optionable
Beta
0.47

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:CHE) was last updated on 1/28/2025 by MarketBeat.com Staff
From Our Partners